Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111217847B reveals novel thiosilane ligands enabling high-yield aryl boronation with superior purification and industrial scalability for pharma intermediates.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API intermediates.
Patent CN113912526B reveals a mild acetate-catalyzed route for N-acetyl tellurate carbamates, offering cost-effective pharma intermediate manufacturing.
Patent CN109761984B details a novel ruthenium-catalyzed asymmetric hydrogen transfer method for synthesizing chiral purine nucleosides with high enantioselectivity and mild conditions.
This report analyzes patent CN107382856A for isoquinoline synthesis. It offers mild conditions and high yields. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and cost reduction.
Patent CN109970643A reveals metal-free tetrahydroacridine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.
Patent CN116283761B reveals green synthesis for quinoline-2-one derivatives. Water-based process ensures cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced palladium-catalyzed method for high-purity intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing processes.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes production with enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN114751937B reveals a novel Friedel-Crafts route for Baryphos intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel palladium-catalyzed route offers mild conditions and significant cost reduction in pharmaceutical intermediate manufacturing for global supply chains and strategic partners.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel asymmetric oxidative coupling method for chiral spiro indolones using cinchona catalysts. High yield, mild conditions, scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Novel FeCl3-catalyzed route offers high yield and scalability for drug intermediates, reducing costs in API manufacturing.
Novel silver oxide promoted method for high purity imidazole intermediates. Cost effective scalable process ensuring supply chain reliability.
Patent CN115637454A reveals a green electrochemical route for tetrahydroimidazo[1,5-a]quinoxalin-4(5H)-one derivatives, offering cost-effective API intermediate manufacturing.